Application of dioscorea nipponica dioscin in inhibition of atherosclerotic plaque
Through the application of Chuanshanlong Diosperm, the prevention and treatment problems of atherosclerosis-related diseases have been solved, which significantly inhibits plaque formation and calcification, improves the health of blood vessel walls, reduces the risk of cardiovascular events, and achieves more atherosclerosis Improvement in aspects.
Patent Information
- Application Number
- CN202411164516.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-12-03
AI Technical Summary
The prior art has not effectively prevented and treated atherosclerosis-related diseases, especially in postmenopausal women with atherosclerosis-related cardiovascular and cerebrovascular diseases, and the existing treatment methods have given atherosclerosis plaques. The stability and calcification phenomenon are difficult to effectively control.
Using citronellin as a drug, by inhibiting the formation of atherosclerotic plaques, reducing the damage to the aortic blood vessel wall, improving blood vessel wall thickness, reducing white crystallization and calcification in the endometrial plaques, regulating blood lipids and inflammatory responses, significantly Reduce the risk of disease progression.
Cishanlong Diosperm significantly inhibits the formation of atherosclerotic plaques, improves blood vessel wall thickening and inflammatory response, reduces calcification, and reduces the risk of cardiovascular events. It has a multi-target effect in preventing and treating atherosclerosis, which significantly reduces the Risk of disease progression.
Smart Images

Figure CN119055664A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of medical technology, and more specifically to the application of dioscorea zingiberensis saponin in inhibiting atherosclerotic plaques. Background Art
[0002] In postmenopausal women, the incidence of cardiovascular and cerebrovascular diseases related to atherosclerosis (AS) increases significantly with age. Atherosclerosis is an important risk factor for a variety of cardiovascular events. Its main characteristics are the deposition of lipids in the arterial wall and the infiltration of inflammatory cells. It is a pathological process dominated by chronic inflammatory response.
[0003] During the development of atherosclerosis, plaque inflammation occurs because circulating monocytes cross the damaged vascular endothelium, migrate to the subintima of the artery, and differentiate into macrophages. These macrophages take up oxidized low-density lipoprotein (oxLDL) and transform into lipid-rich foam cells. Foam cells secrete matrix metalloproteinases in plaques, leading to degradation of the fibrous cap on the plaque. At the same time, foam cell efferocytosis is inhibited, leading to the gradual accumulation of necrotic cores. In addition, activated macrophages also secrete chemokines to attract other immune cells (such as T cells) to the plaque, and T cells further secrete cytokines to maintain the phenotype of proinflammatory macrophages, thereby exacerbating chronic vascular inflammation. These processes together lead to the instability of plaque morphology, increase the risk of rupture, and thus trigger ischemic events.
[0004] Dioscorea nipponica Makino is the dried rhizome of Dioscorea nipponica Makino, a plant of the Dioscoreaceae family. It tastes sweet and bitter, is warm in nature, and mainly enters the liver, kidney, and lung meridians. Modern research shows that the main active ingredient in Dioscorea nipponica Makino is dioscorea saponin, which has a wide range of pharmacological effects, including anti-inflammatory and analgesic, anti-tumor, immune regulation, lipid-lowering, antiviral, and blood sugar-lowering.
[0005] However, to date, there has been no application of Dioscorea zingiberensis saponins in the prevention and treatment of diseases associated with atherosclerosis. Summary of the invention
[0006] In order to explore a drug capable of preventing and treating diseases associated with atherosclerosis, the present invention discloses an application of Dioscorea zingiberensis saponin in inhibiting atherosclerotic plaques.
[0007] Furthermore, the present invention also discloses the use of Dioscorea zingiberensis saponin in reducing aortic vascular wall damage; and the use of Dioscorea zingiberensis saponin in improving vascular wall thickening, the number of white crystals in the local cavity of intimal plaques, and local tissue calcification of intimal plaques.
[0008] By adopting the above technical scheme, the present invention shows significant effects in preventing and treating diseases related to atherosclerosis by applying Dioscorea zingiberensis. Dioscorea zingiberensis can effectively inhibit the formation of atherosclerotic plaques and improve the pathological changes caused by atherosclerosis in many aspects. It can reduce the damage of the aortic vascular wall, significantly improve the condition of vascular wall thickening, reduce the number of white crystals in the local cavity of the intimal plaque, and effectively reduce the incidence of local tissue calcification of the intimal plaque. Through these multi-target therapeutic effects, Dioscorea zingiberensis can comprehensively deal with the complex pathological process of atherosclerosis and significantly reduce the risk of disease progression.
[0009] In addition, Dioscorea zeylanicum not only shows a strong therapeutic effect in treating established atherosclerotic plaques, but also shows the potential to prevent the occurrence of atherosclerosis. Early intervention with Dioscorea zeylanicum can play a preventive role in the early stages of the disease or in high-risk groups, significantly reducing the incidence of atherosclerosis. By reducing white crystals and calcification in arterial plaques, Dioscorea zeylanicum can also effectively reduce the risk of rupture of atherosclerotic plaques, thereby reducing the occurrence of cardiovascular events.
[0010] Another object of the present invention is to provide a method for verifying the effect of Dioscorea zingiberensis saponins in inhibiting atherosclerotic plaques, comprising the following steps:
[0011] S1: Select ApoE- / - female mice and feed them with high fat;
[0012] S2: Weigh the mice before surgery, fix them after anesthetizing them, and shave the hair in the incision area;
[0013] S3: Make a 1 cm longitudinal incision along the spine 1.5 cm on each side at the lower 1 / 3 of the mouse's back trunk. After separating the muscle layer, find and ligate the ovary. After removal, reposition the tissue and suture the incision. Observe the mouse's condition after surgery.
[0014] S4: The mice that survived step S3 continued to be fed with a high-fat diet; the mice in the sham operation group only underwent incision treatment, with their ovaries retained, without ligation;
[0015] S5: The mice with successful ovariectomy were randomly divided into two groups. The sham operation group served as the control group. Mice in all groups continued to be fed a high-fat diet and received drug intervention. The weight and appearance changes of the mice were monitored weekly, and the drug dosage was adjusted according to the weight.
[0016] Furthermore, the random grouping described in step S5 includes the following groups: model group, atorvastatin group, estradiol group, atorvastatin + estradiol group, monomer low-dose group, monomer medium-dose group, monomer high-dose group.
[0017] Furthermore, the following steps are included: S6: After administration, the mice are killed, fasted but allowed to drink water, weighed, the eyes are removed to collect blood, allowed to stand and then centrifuged to separate the serum, the aorta is cut after dissection, the aorta of the mice is fixed with fixative, and stained with Oil Red O, HE and Masson staining; the remaining aortic tissue is quickly frozen in liquid nitrogen for gene and protein detection.
[0018] Furthermore, the specific parameters of the centrifugation after standing in step S6 are standing at room temperature for 2 hours and centrifugation at 3000 rpm for 15 minutes.
[0019] Furthermore, the gene and protein detection described in step S6 mainly includes serum detection and tissue detection; the serum detection includes lipid metabolism related index detection, inflammatory factor related index detection and estrogen level related index detection.
[0020] Furthermore, the specific method of tissue detection includes:
[0021] SS1: A complete whole aorta was carefully isolated from each group of mice and fixed with 4% paraformaldehyde for Oil Red O staining. The isolated aorta samples and frozen aortic root sections were sliced for lipid deposition assessment and observation of the area and location of atherosclerotic plaques.
[0022] SS2: Frozen sections of the aortic root were stained with HE and Masson to observe the number of necrotic cores, collagen content, and fiber content in the plaques at the aortic root and aortic valve, respectively.
[0023] By adopting the above technical scheme, the present invention adopts an ApoE- / - female mouse model, which can effectively simulate the pathological changes of human atherosclerosis. The ovariectomy operation reduces the influence of endogenous estrogen, which further highlights the effect of the drug. The method not only performs routine monitoring of the weight and appearance changes of the mice, but also includes the detection of lipid metabolism, inflammatory factors and estrogen levels in the serum, and evaluates the pathological changes in various aspects such as plaque area, lipid deposition, and internal structure of plaques through tissue detection, further verifying the mechanism of action of Dioscorea zingiberensis saponins.
[0024] The present invention observes the structure, lipid deposition, fibrosis, etc. of the aorta in detail through Oil Red O, HE, and Masson staining, and can accurately evaluate the morphology and property changes of atherosclerotic plaques, so that the effects of Dioscorea zingiberensis on different aspects of arterial plaques can be carefully observed, thereby more comprehensively demonstrating the potential therapeutic effect of the drug; and by quick-freezing the aorta tissue with liquid nitrogen, and performing gene and protein detection, the mechanism of action of Dioscorea zingiberensis at the molecular level can be deeply revealed, and its effect in preventing and treating atherosclerosis can be further supported, so that it can be clarified that the drug affects lipid metabolism, inflammatory response, and changes in vascular wall structure, and can provide an important basis for subsequent drug development and application.
[0025] In summary, the present invention has the following beneficial effects:
[0026] 1. The present invention studies and discloses the application of Dioscorea zingiberensis in preventing and treating atherosclerosis and related diseases. The drug can not only significantly inhibit the formation of atherosclerotic plaques, but also improve related pathological changes in many aspects, reduce vascular wall damage, improve vascular wall thickening, and reduce white crystals and calcification. Dioscorea zingiberensis also has the characteristics of regulating blood lipids, improving hormone balance and reducing inflammation, and has potential application value in improving endocrine disorders related to atherosclerosis. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 : is an Oil Red O staining image of the whole aorta of APOE- / - mice in the embodiment of the present invention; wherein, Figure A is a representative image of the gross staining of the whole aorta with Oil Red O, and Figure B is a relative quantitative analysis image of the plaque area of the whole aorta;
[0028] Figure 2 1 is an Oil Red O staining diagram of aortic root sections of APOE- / - mice in an embodiment of the present invention; wherein, Figure A is a representative image of Oil Red O staining of aortic root sections, and Figure B is a relative quantitative analysis diagram of aortic root plaque area;
[0029] Figure 3 1 is a HE staining image of the aorta root of APOE- / - mice in an embodiment of the present invention; wherein, Figure A is a representative image of the HE staining image of the aorta root, and Figure B is a relative quantitative analysis image of the intima thickness;
[0030] Figure 4 1 is a Masson staining diagram of the aortic root of APOE- / - mice in an embodiment of the present invention; wherein, Figure A is a representative image of the Masson staining diagram of the aortic root, and Figure B is a relative quantitative analysis diagram of the collagen fiber content;
[0031] Figure 5This is a relative quantitative analysis diagram of hormone levels in APOE- / - mice in an embodiment of the present invention;
[0032] Figure 6 This is a relative quantitative analysis of lipid levels in APOE- / - mice in an embodiment of the present invention;
[0033] Figure 7 This is a relative quantitative analysis chart of inflammatory factors in APOE- / - mice in an embodiment of the present invention. DETAILED DESCRIPTION
[0034] The following is combined with Figure 1-7 The present invention is further described in detail. The following non-limiting examples can enable a person skilled in the art to more fully understand the present invention, but do not limit the present invention in any way.
[0035] Example: Application of Dioscorea zingiberensis saponins in inhibiting atherosclerotic plaques
[0036] 1. Experimental Animals
[0037] 78 SPF-grade 8-week-old female ApoE- / - female mice [strain C57BL / 6J], weighing 18-22 g, were purchased from Beijing Jinmuyang Experimental Animal Breeding Co., Ltd., license number: SCXK (Beijing) 2021-0013. The breeding conditions were level 2, the room temperature was maintained at (22 ± 2) ° C, the relative humidity was (55 ± 5)%, and the light time was 7:00-19:00.
[0038] 2.1 Feed
[0039] High-fat feed for mice [77.8% basic feed + 10% lard + 10% egg yolk powder + 2% cholesterol + 0.2% bile salt]: provided by Xiaoshu Youtai, item number D12108C.
[0040] 2.2 Drugs
[0041] ① Atorvastatin calcium tablets (trade name: Lipitor): Pfizer Pharmaceuticals Co., Ltd., batch number: FK8380, 10 mg per tablet. According to the "Equivalent Dose Ratio Table for Human and Animal Body Surface Area", 1 mg / (person·d), the dosage for mice was converted to atorvastatin 10 mg / kg / d for oral administration.
[0042] ② Estradiol valerate tablets (trade name: Progynova): Bayer Healthcare Co., Ltd., batch number: 219A2, 1 mg per tablet. According to the "Equivalent Dose Ratio Table for Human and Animal Body Surface Area", 1 mg / (person·d), the dose for mice was converted to estradiol valerate concentration of 0.135 mg / kg / d.
[0043] ③Monomer: Dioscorea zingiberensis saponin (Biopurify, Lot: PRF21062141), low-dose group 35 mg / kg / d, medium-dose group 70 mg / kd / d, high-dose group 140 mg / kg / d.
[0044] 3. Establishment and grouping of the atherosclerosis model in ovariectomized mice
[0045] S1: ApoE- / - female mice were fed a high-fat diet for 8 weeks and then underwent ovariectomy.
[0046] S2: Before surgery, the mice were weighed and 5% chloral hydrate was injected intraperitoneally at 0.1 ml / 10 g. The abdomen was fixed and the back incision was shaved with a mouse razor.
[0047] S3: Make a longitudinal incision of about 1 cm in length in the lower 1 / 3 of the back trunk, 1-2 cm away from both sides of the spine. After separating the muscle layer, a pale yellow fat mass can be seen. Pull out the fat mass with small tweezers and you will find a group of irregular, flesh-colored tissues, which are the ovaries. The thick tubular tissues below are the uterine horns. At this time, thread a silk thread through the lower end of the ovaries and ligate them. Remove the ovaries and the remaining thread, return the tissues to the abdominal cavity, suture the incision, and put the mice back in the cage. Observe the surgical incision status, respiratory rate, etc. of the mice at any time.
[0048] S4: 24 hours after surgery, the surviving mice were fed a high-fat diet. The ApoE- / - mice in the sham operation group underwent the same incision, but only threading was performed without ligation, the ovaries were retained, and the incision was sutured.
[0049] S5: The castrated mice were randomly divided into 7 groups: model group, atorvastatin group, estradiol group, atorvastatin + estradiol group, monomer low-dose group, monomer medium-dose group, monomer high-dose group, and sham operation group as control group, a total of 8 groups, 12 mice in each group, as shown in Table 1 below. They were fed with high-fat diet and given drug intervention for 8 weeks. The appearance and body weight of the mice were tested every week. The drug dose for oral administration of mice was calculated according to the common dose recommended by the clinical practice of daily medication for adults, and the body weight was recorded every week to adjust the drug dose.
[0050] Sham operation group: bilateral ovarian incision was performed to preserve the ovaries, and the mice were fed with high-fat diet and gavage with distilled water once a day;
[0051] Model group: bilateral ovariectomy, high-fat diet + distilled water gavage once a day;
[0052] Atorvastatin group: bilateral ovariectomy, high-fat diet + oral administration of atorvastatin calcium tablets 10 mg / kg / d, once a day;
[0053] Estradiol group: bilateral ovariectomy, high-fat diet feeding + 0.135 mg / kg / d oral administration, once a day;
[0054] Atorvastatin + estradiol group: bilateral ovariectomy, high-fat diet + atorvastatin calcium tablets 10 mg / kg / d + 0.135 mg / kg / d estradiol gavage, once a day;
[0055] Single low-dose group: bilateral ovariectomy, high-fat diet feeding + 35 mg / kg / d oral gavage, once a day;
[0056] Monomer medium-dose group: bilateral ovariectomy, high-fat diet feeding + 70 mg / kg / d oral gavage, once a day;
[0057] Single high-dose group: bilateral ovariectomy, high-fat diet feeding + 140 mg / kg / d oral gavage, once a day.
[0058] Table 1 Experimental animal grouping and drug administration
[0059]
[0060]
[0061] 4. Specimen Collection
[0062] The animals were killed after administration, and fasted for 12 hours before killing, but not water. The mice were weighed, the eyeballs were removed and blood was collected, which was left to stand at room temperature for 2 hours, centrifuged at 3000rpm for 15 minutes, and the serum was separated. After the mice were dissected, the aorta was cut. The complete aortas of 5 mice in each group were fixed in a 15ml centrifuge tube with 4% tissue fixative for Oil Red O macroscopic staining, HE and Masson staining; the aortic tissues of the remaining mice were quickly frozen with liquid nitrogen and then transferred to -80℃ for storage for subsequent gene and protein detection.
[0063] 5. Experimental testing
[0064] 5.1 Serological testing:
[0065] Detection of lipid metabolism-related indicators: The test kit micro-method was used to determine the levels of serum total cholesterol (TG), triglycerides (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C).
[0066] The test results are as attached Figure 6As shown, APOE- / - mice showed significant differences in lipid levels among different experimental groups. Compared with the sham operation group, the model group had significantly increased levels of total cholesterol (TC), triglycerides (TG), and low-density lipoprotein (LDL) (P<0.001), and at the same time, the high-density lipoprotein (HDL) level was significantly decreased (P<0.001); compared with the model group, the monomer treatment group had significantly decreased levels of TC and LDL (P<0.001) in the mice treated with low, medium, and high doses of monomer, indicating that these treatments had a good regulatory effect on dyslipidemia. In terms of triglycerides (TG), the TG levels of the low-dose group (P<0.05) and the high-dose group (P<0.001) were significantly decreased, indicating that the improvement of TG levels showed obvious effects under both low-dose and high-dose treatments. In terms of high-density lipoprotein (HDL), the HDL levels of the low-dose group (P<0.001) and the high-dose group (P<0.05) were significantly increased, indicating that low-dose and high-dose monomer treatments had a positive effect on improving HDL levels.
[0067] Therefore, Dioscorea schrenkiana saponins at different doses significantly improved the lipid levels of APOE- / - mice, especially reducing TC, LDL and TG levels and increasing HDL levels. These results show that Dioscorea schrenkiana saponins have the potential to regulate blood lipids and prevent atherosclerosis.
[0068] Detection of inflammatory factor-related indicators: Elisa kit was used to measure TNF-α, IL-1β, and IL-6.
[0069] The test results are as attached Figure 7 As shown in the figure, the levels of inflammatory factors in APOE- / - mice in different experimental groups showed significant differences. Compared with the sham operation group, the levels of inflammatory factors TNF-α, IL-1β, and IL-6 in the model group were significantly increased (P<0.001), indicating that there was an obvious inflammatory response in the model group; compared with the model group, the levels of TNF-α in the monomer treatment group were significantly decreased in the mice treated with low, medium, and high doses of the monomer. Among them, low-dose (P<0.05), medium-dose (P<0.05), and high-dose (P<0.001) treatments can effectively reduce the level of TNF-α. For IL-1β, the IL-1β level of mice in the low-dose (P<0.001) and high-dose (P<0.05) treatment groups was significantly decreased, indicating that the monomer treatment has a dose-dependent effect in reducing the level of IL-1β. The level of IL-6 was also significantly decreased in the low-dose (P<0.05) and high-dose (P<0.05) treatment groups, which further proves that the monomer treatment can effectively reduce the inflammatory response.
[0070] In summary, Dioscorea zingiberensis saponins at different doses can significantly reduce the levels of inflammatory factors in APOE- / - mice, especially the levels of TNF-α, IL-1β and IL-6. The results show that Dioscorea zingiberensis saponins have significant anti-inflammatory effects and have potential application value in preventing and alleviating inflammatory responses associated with atherosclerosis.
[0071] Detection of estrogen level-related indicators: Elisa kit was used to measure the expression of estradiol (E2) and progesterone (Prog).
[0072] The test results are as attached Figure 5 As shown in the figure, the hormone levels (mainly estrogen and progesterone) of APOE- / - mice in different experimental groups showed significant differences. Compared with the sham operation group, the estrogen and progesterone levels of mice in the model group were significantly decreased (P < 0.001), indicating that the levels of these hormones were inhibited in the atherosclerosis model; compared with the model group, the estrogen and progesterone levels of mice given estradiol in the treatment group were significantly increased (P < 0.001), indicating that exogenous estradiol can effectively restore the levels of these hormones; in the treatment group combined with atorvastatin and estradiol, the hormone levels were also significantly increased (P < 0.001), showing the regulatory effect of combined treatment on hormone levels. The estrogen and progesterone levels of mice in the medium dose (P < 0.05) and high dose (P < 0.001) groups treated with monomers were also significantly increased, indicating that monomer treatment has a significant improvement effect on hormone levels at medium and high doses.
[0073] In summary, the treatment of estradiol and Dioscorea zingiberensis can significantly increase the levels of estrogen and progesterone in APOE- / - mice, especially under medium and high doses of monomer treatment, the improvement of these hormone levels is more significant. The results show that Dioscorea zingiberensis has potential application value in regulating hormone balance and improving endocrine disorders related to atherosclerosis.
[0074] 5.2 Organization testing:
[0075] Detection method: A complete aorta was carefully separated from each group of mice and fixed with 4% paraformaldehyde for Oil Red O staining. Lipid deposition was evaluated in isolated aortic samples and frozen aortic root sections (10 μm thick) to observe the area and location of atherosclerotic plaques.
[0076] Detection conclusion: The representative images of the whole-length aorta Oil Red O stained samples and the relative quantitative analysis of the plaque area of the whole-length aorta are shown in the attached figure. Figure 1As shown in the figure, the experimental results showed that in the atherosclerosis model, the plaque area of the whole aorta of the model group mice was significantly increased compared with that of the sham operation group mice (P<0.001). This indicates that atherosclerosis was successfully induced in the model group mice.
[0077] However, when the positive drugs atorvastatin or estradiol were administered, the area of full-length plaques in the aorta of mice was significantly reduced (P < 0.001), which verified the effectiveness of these drugs in inhibiting the formation of atherosclerotic plaques. In addition, the area of full-length plaques in the aorta of mice given different doses of Dioscorea zingiberensis alone (low dose, medium dose and high dose) was reduced, among which the inhibitory effects of the medium dose and high dose groups were particularly significant (P < 0.001), and the low dose group also showed a certain inhibitory effect (P < 0.05). These results show that Dioscorea zingiberensis can effectively reduce the formation of atherosclerotic plaques at different doses, and its effect is more obvious at higher doses.
[0078] Detection method: HE and Masson staining were performed on frozen sections of the aortic root to observe the number of necrotic cores, collagen content, and fiber content in the plaques at the aortic root and aortic valve, respectively.
[0079] Test conclusion 1: The observation results of the aortic root are as follows Figure 2 As shown, according to the attached Figure 2 The experimental results showed that the plaque area at the aortic root of APOE- / - mice showed significant changes in different experimental groups; specifically, compared with the mice in the sham operation group, the plaque area at the aortic root of the model group mice was significantly increased (P < 0.001), indicating that atherosclerosis was successfully induced in the model group mice, which was consistent with the previous full-length aorta experimental results; in mice given different treatments, whether it was atorvastatin, estradiol, or atorvastatin + estradiol combined, the plaque area at the aortic root was significantly reduced (P < 0.001), which once again verified the effectiveness of these drugs in inhibiting atherosclerosis.
[0080] In addition, mice given Dioscorea zingiberensis alone also showed a dose-dependent effect. The plaque area of the low-dose, medium-dose, and high-dose groups was significantly reduced (P < 0.001), and the effects of the medium and high-dose groups were particularly significant. This shows that the inhibitory effect of Dioscorea zingiberensis on atherosclerosis is not limited to the entire aorta, but also has a significant effect in the aortic root. Dioscorea zingiberensis also showed a good effect of inhibiting the formation of atherosclerotic plaques in the aortic root of APOE- / - mice, and its effect was dose-dependent, which further supports the application prospects of Dioscorea zingiberensis as a potential treatment for atherosclerosis.
[0081] Test conclusion 2: The results of HE staining of the aortic root and the relative quantitative analysis of the thickness of the intima are shown in the attached figure. Figure 3 As shown, according to the attached Figure 3 The experimental results showed that the pathological changes of the aortic root of APOE- / - mice showed significant differences in each experimental group through HE staining. In the sham operation group, the aortic valve of the mice showed damage, obvious atherosclerosis in the vascular wall, thickening of the vascular intima, smaller tricuspid valve chamber, local cavities in the intimal hyperplasia plaques, and white crystals were visible in the cavities. In the model group, the aortic vascular wall of the mice showed more severe damage, the atherosclerosis on the intima was significantly aggravated, and the thickness of the vascular intima was significantly increased (P < 0.001). In addition, more cavities appeared locally in the intimal plaques of the mice in the model group, which were filled with a large number of white crystals, and calcification of the local tissue of the intimal plaques was also observed. These changes indicate that the atherosclerotic lesions of the mice in the model group are severe and the vascular pathological damage is significant.
[0082] However, after being given positive drugs or Dioscorea zingiberensis saponins, whether low-dose, medium-dose or high-dose, the mice in these treatment groups showed varying degrees of pathological improvement. Specifically, the damage to the aortic wall was reduced, the atherosclerosis of the vascular intima was reduced, and the thickness of the intima became thinner. In addition, the white crystals in the local cavity of the intima plaque decreased, and tissue calcification also decreased (P < 0.001). These results show that these drugs and natural compounds have a significant inhibitory effect on the progression of atherosclerosis and can reduce pathological damage to blood vessels.
[0083] Therefore, the HE staining images of the aortic root of APOE- / - mice further verified the role of atorvastatin, estradiol and Dioscorea zingiberensis in inhibiting the development of atherosclerosis, showing that they can effectively reduce pathological damage to arterial vessels and reduce calcification and crystal formation in lesions. Dioscorea zingiberensis showed good effects at different doses, especially at medium and high doses.
[0084] Test conclusion 3: The results of Masson staining of the aortic root and the relative quantitative analysis of collagen fiber content are shown in the attached figure. Figure 4 As shown, according to the attached Figure 4The experimental results showed that the collagen fiber structure of the aortic root of APOE- / - mice showed significant differences in different experimental groups through Masson staining. In the blank group mice, the aorta had a dense structure, and the collagen fibers were neatly arranged, showing a normal vascular tissue structure. Compared with the blank group, the aortic root of the model group mice showed obvious pathological changes. Specifically, the collagen fiber structure at the base of the blood vessels was loose, there was obvious breakage, and the collagen content was significantly reduced (P < 0.001). These changes indicate that in the process of atherosclerosis progression in the model group mice, the vascular structure was severely damaged, and the normal arrangement and content of collagen fibers changed significantly.
[0085] In the experimental group treated with monomers, no matter low dose, medium dose or high dose, the collagen fiber content inside the plaque was observed to increase, and the looseness and disorder of the vascular tissue at the base were significantly improved (P < 0.001). This shows that monomer treatment can effectively improve the abnormal collagen fiber structure caused by atherosclerosis and help restore the normal morphology and function of vascular tissue. The results of Masson staining images further verified the positive role of Dioscorea zingiberensis monomer treatment in improving the collagen fiber structure and vascular base tissue status in atherosclerotic plaques. These results show that Dioscorea zingiberensis can not only inhibit plaque formation, but also repair vascular damage to a certain extent and enhance the structural integrity and function of the vascular wall.
[0086] 6. Data collation and statistical analysis
[0087] All the above experimental results were statistically analyzed using GraphPadPrism 8 software, and the results were expressed as "mean ± standard deviation". For inter-group data comparison, if they conformed to normal distribution and had equal variance, one-way analysis of variance (ANOVA) was used. If they did not conform to normal distribution, non-parametric tests were required. P < 0.05 was considered to be statistically significant.
[0088] This specific embodiment is merely an explanation of the present invention and is not a limitation of the present invention. After reading this specification, those skilled in the art may make non-creative modifications to the present embodiment as needed. However, as long as they are within the scope of the claims of the present invention, they are protected by the patent law.
Claims
1. Application of Dioscorea zingiberensis saponins in inhibiting atherosclerotic plaques.
2. The use of Dioscorea zingiberensis saponin in inhibiting atherosclerotic plaques according to claim 1, characterized in that: The application of Dioscorea zingiberensis saponins in reducing aortic vascular wall damage; the application of Dioscorea zingiberensis saponins in improving vascular wall thickening, the number of white crystals in the local cavity of intimal plaques, and local tissue calcification of intimal plaques.
3. A method for verifying the effect of Dioscorea zingiberensis saponins in inhibiting atherosclerotic plaques, characterized by: The following steps are involved: S1: Select ApoE- / - female mice and feed them with high fat; S2: Weigh the mice before surgery, fix them after anesthetizing them, and shave the hair in the incision area; S3: Make a 1 cm longitudinal incision along the spine 1.5 cm on each side at the lower 1 / 3 of the mouse's back trunk. After separating the muscle layer, find and ligate the ovary. After removal, reposition the tissue and suture the incision. Observe the mouse's condition after surgery. S4: The mice that survived step S3 continued to be fed with a high-fat diet; the mice in the sham operation group only underwent incision treatment, with their ovaries retained, without ligation; S5: The mice with successful ovariectomy were randomly divided into two groups. The sham operation group served as the control group. Mice in all groups continued to be fed a high-fat diet and received drug intervention. The weight and appearance changes of the mice were monitored weekly, and the drug dosage was adjusted according to the weight.
4. The method according to claim 3, characterized in that: The random grouping described in step S5 includes the following groups: model group, atorvastatin group, estradiol group, atorvastatin + estradiol group, monomer low-dose group, monomer medium-dose group, monomer high-dose group.
5. The method according to claim 3, characterized in that it also includes the following steps: S6: After administration, the mice were killed, fasted but allowed to drink water, weighed, and their eyes were removed to collect blood. The blood was centrifuged after standing to separate the serum, and the aorta was cut after dissection. The aorta of the mice was fixed with fixative and stained with Oil Red O, HE and Masson staining; the remaining aortic tissue was quickly frozen in liquid nitrogen for gene and protein detection.
6. The method according to claim 5, characterized in that: The specific parameters of the centrifugation after standing in step S6 are standing at room temperature for 2 hours and centrifuging at 3000 rpm for 15 minutes.
7. The method according to claim 5, characterized in that: The gene and protein detection described in step S6 mainly includes serum detection and tissue detection; the serum detection includes lipid metabolism related index detection, inflammatory factor related index detection and estrogen level related index detection.
8. The method according to claim 7, characterized in that: The specific method of tissue detection includes: SS1: A complete whole aorta was carefully isolated from each group of mice and fixed with 4% paraformaldehyde for Oil Red O staining. The isolated aorta samples and frozen aortic root sections were sliced for lipid deposition assessment and observation of the area and location of atherosclerotic plaques. SS2: Frozen sections of the aortic root were stained with HE and Masson to observe the number of necrotic cores, collagen content, and fiber content in the plaques at the aortic root and aortic valve, respectively.
Citation Information
Patent Citations
Steroidal saponin pharmaceutical composition, the preparation method and use thereof
CN101035548A
Application of dioscorea panthaica prain et burk and / or dioscorea nipponica makino steroidal total saponins extract in preparing medicine promoting reverse cholesterol transport
CN108143880A
Functional food preventing from hyperlipidemia or arteriosclerosis
KR1020040077648A
Plant based formulation for the prevention and management of metabolic syndrome and cardiovascular disease mortality risk
US20160051615A1
